PBM ▼ -9.8% - Psyence Biomedical Ltd. $PBM - Psyence BioMed Announces Strategic Ibogaine Investment Psyence Biomedical fell 9.8% today despite announcing a strategic investment in ibogaine, its lead therapeutic candidate for treating addiction disorders. The market reaction suggests investors may have concerns about the investment terms, dilution, or broader skepticism about the company's development timeline and commercial prospects in the psychedelic medicine space. 23-SEP-2026 07:00 AM ET